Coca-Cola's second-quarter margins and first-half cash flow both improved, but the two improvements are not the same kind of event. Operating margin expanded to 34.92% from 34.14%, and operating cash flow for the first half swung to $7,543 million from negative $1,391 million a year earlier — an $8,934 million reversal, of which $6,173 million (69%) is simply the absence of the fairlife contingent-consideration payment made in March 2025. Adding that payment back to the prior-year base gives a like-for-like comparison of $7,543 million against $4,782 million, still a 57.7% increase — so there is genuine underlying improvement, just less than a third of what the headline swing implies. Meanwhile, the U.S. Court of Appeals for the Eleventh Circuit heard the company's transfer-pricing appeal on June 25, 2026, leaving $6.0 billion already paid to the IRS plus $514 million of accrued interest receivable awaiting a ruling the company has reserved only $529 million against — and, separately, a disclosed potential incremental liability of roughly $14 billion for the 2010–2025 tax years that appears nowhere on the balance sheet. For a defensive staple that trades on the predictability of its cash returns, the single largest swing factor is now a court decision, and most of that exposure is off-balance-sheet.
Note on period and sources: all financial figures are drawn from Coca-Cola's Form 10-Q for the three and six months ended July 3, 2026, filed July 29, 2026 — the company's second quarter of fiscal 2026 — unless otherwise noted. Quarterly periods other than Q4 end on the Friday closest to the calendar quarter-end. Volume, organic revenue, comparable EPS and guidance figures are from the company's Q2 2026 earnings release dated July 28, 2026.
What the earnings release led with. The 10-Q is the source for everything below, but the numbers that moved the stock came from the July 28 release: unit case volume up 5%, organic (non-GAAP) revenue up 6%, and comparable EPS of $0.97, up 11%. Management raised full-year guidance to roughly 5% organic revenue growth and 9–10% all-in comparable EPS growth. Note the gap between comparable EPS of $0.97 and reported diluted EPS of $1.03 for the quarter — the difference is the non-operating gains discussed in section 2-1, which is precisely why the reported figures below need normalizing before they are compared with anything.
1. Consolidated Balance Sheet
1-1. Major Asset Items
Coca-Cola's quarterly periods are seasonal — the filing states that the second and third calendar quarters typically account for the highest sales volumes. Comparing a July 3 balance sheet against a December 31 balance sheet therefore overstates working-capital "growth," and receivables in particular should be read with that distortion in mind.
| Item | Dec 31, 2025 ($M) | Jul 3, 2026 ($M) | Change % |
|---|---|---|---|
| Cash and cash equivalents | 10,270 | 12,907 | +25.7% |
| Short-term investments | 3,602 | 622 | −82.7% |
| Marketable securities | 1,934 | 2,842 | +46.9% |
| Trade accounts receivable | 3,038 | 3,732 | +22.8% |
| Inventories | 4,425 | 4,647 | +5.0% |
| Property, plant and equipment (net) | 9,613 | 9,636 | +0.2% |
| Trademarks with indefinite lives | 12,531 | 12,500 | −0.2% |
| Goodwill | 15,491 | 15,456 | −0.2% |
| Equity method investments | 20,235 | 20,782 | +2.7% |
| Assets held for sale | 5,342 | 5,438 | +1.8% |
| Other noncurrent assets | 14,696 | 15,582 | +6.0% |
| Total assets | 104,816 | 107,922 | +3.0% |
The headline cash increase is largely a reclassification. Cash rose $2,637 million while short-term investments fell $2,980 million, so total cash, cash equivalents and short-term investments actually declined slightly to $13,529 million from $13,872 million. Adding marketable securities, total liquid resources reached $16,371 million against $15,806 million at year-end — a genuine but modest $565 million build.
Receivables growing 22.8% against half-year revenue growth of 9.2% looks alarming in isolation, but the year-end base is a seasonal trough and the allowance for doubtful accounts was essentially unchanged at $492 million versus $495 million. Inventories grew 5.0%, well below revenue growth, indicating no build-up of unsold product.
Two hard-asset lines deserve attention for what they did not do. Net property, plant and equipment was flat at $9,636 million on a $107,922 million balance sheet — 8.9% of total assets — confirming that Coca-Cola remains a concentrate licensor rather than a manufacturer. Goodwill and indefinite-lived trademarks together stand at $27,956 million, 25.9% of assets, and neither moved materially, so no impairment was triggered this half.
Other noncurrent assets rose 6.0% to $15,582 million. This line carries the $6.0 billion IRS Tax Litigation Deposit and the related $514 million accrued interest receivable — roughly 42% of the balance is a contingent claim against the U.S. government rather than an operating asset. Under U.S. GAAP, property is carried at historical cost with no revaluation permitted, so the carrying value of long-held plant and trademarks reflects historical cost rather than current value, while this tax receivable is carried at full face pending a ruling.
1-2. Liability Structure — Financial vs. Operating
| Item | Dec 31, 2025 ($M) | Jul 3, 2026 ($M) | Change |
|---|---|---|---|
| Loans and notes payable | 1,551 | 48 | −1,503 |
| Current maturities of long-term debt | 1,822 | 6,494 | +4,672 |
| Long-term debt | 42,119 | 37,001 | −5,118 |
| Total financial debt | 45,492 | 43,543 | −1,949 |
| Accounts payable and accrued expenses | 14,813 | 15,434 | +621 |
| Accrued income taxes | 525 | 782 | +257 |
| Liabilities held for sale | 2,570 | 2,442 | −128 |
Total financial debt fell 4.3% to $43,543 million, and net debt (total debt less cash, short-term investments and marketable securities) declined 8.5% to $27,172 million from $29,686 million. The company retired its commercial paper entirely — Note 8 confirms no outstanding commercial paper borrowings at July 3, 2026 against $1,495 million at year-end.
The maturity profile shifted sharply, however. Current maturities of long-term debt jumped to $6,494 million from $1,822 million, and total debt falling due within twelve months (including loans and notes payable) rose to $6,542 million from $3,373 million — 15.0% of total debt versus 7.4% at year-end. Total short-term obligations of $6,542 million are covered 2.5 times by the $16,371 million of liquid resources, so this is a refinancing scheduling question rather than a liquidity one. The current ratio nonetheless compressed to 1.30 from 1.46 on the same reclassification.
Operating liabilities were well behaved. Accounts payable and accrued expenses grew 4.2%, roughly half the pace of half-year revenue growth. Note 7 discloses $1,431 million of confirmed obligations under the voluntary supply chain finance program against $1,363 million at year-end — 9.3% of payables, and the company provides no guarantees under the program. Payment terms with the majority of suppliers run 120 days, so a portion of reported operating cash flow reflects supplier financing rather than operational efficiency; the modest $68 million increase means this was not a meaningful swing factor this period.
1-3. Capital Structure
Equity attributable to shareowners rose 12.4% to $36,150 million from $32,169 million. The movement reconciles cleanly: reinvested earnings grew $3,787 million ($8,349 million of net income less $4,562 million of dividends), accumulated other comprehensive loss narrowed by $505 million to negative $13,626 million, capital surplus added $160 million, and treasury stock rose $471 million to $56,894 million.
The quality of that equity is worth separating. Paid-in capital (common stock of $1,760 million plus capital surplus of $20,741 million) totals $22,501 million against reinvested earnings of $84,169 million — earnings retained over decades are 3.7 times the capital ever contributed by shareholders. Offsetting this is $56,894 million of treasury stock at cost, the cumulative record of buybacks, which is why book equity of $36,150 million looks small for a company earning $8.3 billion in a half-year.
Shares held in treasury actually fell slightly, to 2,737 million from 2,738 million: $663 million of stock was bought back, but $192 million of issuances and stock-compensation settlements returned marginally more shares to the market than were retired. Shares outstanding — and therefore the diluted count — were effectively unchanged. Total equity, including noncontrolling interests, now funds 35.5% of assets versus 32.7% at year-end; on a shareowners-only basis the ratio is 33.5% against 30.7%.
2. Consolidated Statement of Income
2-1. Core Performance Metrics
| Item | Q2 2025 ($M) | Q2 2026 ($M) | YoY | H1 2025 ($M) | H1 2026 ($M) | YoY |
|---|---|---|---|---|---|---|
| Net operating revenues | 12,535 | 13,380 | +6.7% | 23,664 | 25,852 | +9.2% |
| Gross profit | 7,821 | 8,415 | +7.6% | 14,787 | 16,267 | +10.0% |
| Gross margin (%) | 62.39 | 62.89 | +50bp | 62.49 | 62.92 | +43bp |
| SG&A expenses | 3,470 | 3,720 | +7.2% | 6,704 | 7,192 | +7.3% |
| Other operating charges | 71 | 23 | −67.6% | 144 | 44 | −69.4% |
| Operating income | 4,280 | 4,672 | +9.2% | 7,939 | 9,031 | +13.8% |
| Operating margin (%) | 34.14 | 34.92 | +77bp | 33.55 | 34.93 | +138bp |
| Income before income taxes | 4,796 | 5,475 | +14.2% | 8,853 | 10,086 | +13.9% |
| Income taxes | 993 | 1,037 | +4.4% | 1,715 | 1,682 | −1.9% |
| Effective tax rate (%) | 20.70 | 18.94 | −176bp | 19.37 | 16.68 | −269bp |
| Net income attributable to shareowners | 3,810 | 4,425 | +16.1% | 7,140 | 8,349 | +16.9% |
| Net margin (%) | 30.39 | 33.07 | +268bp | 30.17 | 32.30 | +212bp |
| Diluted EPS ($) | 0.88 | 1.03 | +17.0% | 1.65 | 1.94 | +17.6% |
Operating leverage ran at 1.37x in the quarter (9.2% operating income growth on 6.7% revenue growth) and 1.49x for the half. That is real but flattered by a one-off. Other operating charges fell to $23 million from $71 million in the quarter; excluding this line entirely, operating income grew 7.9% and margin expanded 38 basis points rather than 77 — meaning roughly half the quarterly margin expansion came from the absence of prior-year charges, principally a $40 million Latin American trademark impairment and $28 million held-for-sale charge (Note 12).
The gap between 9.2% operating income growth and 16.1% net income growth in the quarter comes from below the operating line. Net interest expense improved $86 million, as interest expense fell to $369 million from $445 million while interest income rose to $198 million from $188 million. Equity income rose 7.7% to $604 million in the quarter and to $988 million for the half — the half-year figure alone contributes 9.8% of half-year pre-tax income, a reminder that a meaningful slice of Coca-Cola's earnings comes from bottler stakes it does not consolidate. Other income of $386 million in the quarter included a $320 million net gain on equity and trading debt securities and a $66 million reduction of the previously recorded Africa impairment.
Stripping non-operating gains and charges from both years changes the story in opposite directions for the two periods. Removing the $320 million securities gain and $66 million impairment reversal from Q2 2026, and the $163 million securities gain, $102 million India refranchising gain, $40 million impairment and $28 million held-for-sale charge from Q2 2025, gives normalized pre-tax income of $5,089 million against $4,599 million — growth of 10.7% versus the reported 14.2%. For the half the same exercise uses the half-year figures disclosed in Note 12 — a $301 million securities gain and $56 million impairment reversal in 2026, against a $331 million CCEP disposal gain, $144 million securities gain, $102 million India gain and $129 million of impairments, held-for-sale and pension charges in 2025 — and cuts in the company's favor: $9,729 million against $8,405 million, or 15.8% growth versus the reported 13.9%, because the prior-year half contained the CCEP gain that doe